Costs involved in the early and late phases of diabetes mellitus;Kosten in der früh- und spätphase des diabetes mellitus

Internist

Volumn 48, Issue 7, 2007, Pages 708-714

  Liebl, A ^a  

^a Fachklinik Bad Heilbrunn   (Germany)

Author keywords

Complications; Cost effectiveness; Costs; Diabetes mellitus; Epidemiology

Indexed keywords

ANTILIPEMIC AGENT;

COST OF ILLNESS; DIABETIC PATIENT; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

COSTS AND COST ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG COSTS; GERMANY; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; NATIONAL HEALTH PROGRAMS;

EID: 39649120514     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1875-0     Document Type: Review

References (22)

1. Brown JB, Nichols GA, Glauber HS et al. (1999) Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22: 1116-1124
2. CDC Diabetes Cost-effectiveness Group (2002) Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287: 2542-2551
3. Clarke PM, Gray AM, Briggs A et al. (2005) Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 48: 868-877
4. Diabetes-Union D (Hrsg) (2006) Deutscher Gesundheitsbericht Diabetes 2007. Kirchheim, Mainz
5. Greiner W, Krummaker S, Graf von der Schulenburg JM et al. (2006) Krankheitskostenanalyse eines neu aufgetretenen Diabetes mellitus Typ 2. Diabetologie 1: 237-244
6. Hauner H (2006) [The costs of diabetes mellitus and its complications in Germany.]. Dtsch Med Wochenschr 131 (Suppl 8): S240-S242
7. Hauner H, Koster I, Ferber L von (2003) [Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse]. Dtsch Med Wochenschr 128: 2632-2637
8. Koster I, Hauner H, Ferber L von (2006) [Heterogeneity of costs of diabetic patients: the cost of diabetes mellitus study]. Dtsch Med Wochenschr 131: 804-810
9. Koster I, Ferber L von, Ihle P et al. (2006) The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia 49: 1498-1504
10. Liebl A, Neiss A, Spannheimer A et al. (2001) [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]. Dtsch Med Wochenschr (1946) 126: 585-589
11. Liebl A, Neiss A, Spannheimer A et al. (2002) Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2 study. Exp Clin Endocrinol Diabetes 110: 10-16
12. Liebl A, Spannheimer A, Reitberger U et al. (2003) Arzneimitteltherapie und Medikationskosten von Patienten mit Diabetes Typ 2 in Deutschland. Diabetes und Stoffwechsel 12: 145-151
13. Liebl A, Spannheimer A, Reitberger U et al. (2002) [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study]. Med Klin 97: 713-719
14. Mihaylova B, Briggs A, Armitage J et al. (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet 365: 1779-1785
15. Nichols GA, Brown JB (2002) The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 25: 482-486
16. Rathmann W, Haastert B, Icks A et al. (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46: 182-189
17. Schiel R, Muller UA, Stein G (2005) [Costs of therapy of insulin-treated patients with diabetes mellitus in Germany. Results of the JEVIN trial]. Med Klin 100: 453-461
18. Schramm W, Schoffski O, Gortz A et al. (2004) [Disease modelling in diabetes mellitus]. Dtsch Med Wochenschr 129: 2305-2310
19. Ferber L von, Koster I, Hauner H (2006) [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study]. Med Klin 101: 384-393
20. Ferber L von, Koster I, Hauner H (2007) Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes 115: 97-104
21. Wabitsch M, Hauner H, Hertrampf M et al. (2004) Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 28: 307-313
22. WHO (2004) Diabetes action now - An initiative of the World Health Organization and the International Diabetes Federation. Geneva